Tech Company Financing Transactions

Theraclone Sciences Funding Round

Theraclone Sciences closed a $10.6 million Series B financing round on 9/8/2011. Investors included Allegis Capital, Amgen Ventures and Arch Venture Partners.

Transaction Overview

Announced On
9/8/2011
Transaction Type
Venture Equity
Amount
$10,600,000
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1124 Columbia St. 300
Seattle, WA 98104
USA
Email Address
Overview
Theraclone Sciences is a discovery-stage biotech developing novel therapeutic antibodies for the treatment of infectious disease and inflammation. Our proprietary discovery platform allows us to comprehensively screen and identify the rare antibodies that select individuals produce to successfully ward off disease.
Profile
Theraclone Sciences LinkedIn Company Profile
Social Media
Theraclone Sciences Company Twitter Account
Company News
Theraclone Sciences News
Facebook
Theraclone Sciences on Facebook
YouTube
Theraclone Sciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Clifford Stocks
  Clifford Stocks LinkedIn Profile  Clifford Stocks Twitter Account  Clifford Stocks News  Clifford Stocks on Facebook
Chief Financial Officer
Russ Hawkinson
  Russ Hawkinson LinkedIn Profile  Russ Hawkinson Twitter Account  Russ Hawkinson News  Russ Hawkinson on Facebook
Chief Scientific Officer
Kristine Swiderek
  Kristine Swiderek LinkedIn Profile  Kristine Swiderek Twitter Account  Kristine Swiderek News  Kristine Swiderek on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/8/2011: Wildcat Discovery Technologies venture capital transaction
Next: 9/8/2011: Linkage Biosciences venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary